Skip to main content
Veterinary Medicines

Metrocare tablets 250 mg

Authorised
  • Metronidazole

Product identification

Medicine name:
Metrocare tablets 250 mg
Metrocare Vet 250 mg Tablett
Active substance:
  • Metronidazole
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Metronidazole
    250.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01XD01
  • QP51AA01
Authorisation status:
  • Valid
Authorised in:
  • Sweden
Available in:
  • Sweden
Package description:
  • PVC Aluminium Oriented polyamide Aluminium blister packs.Cardboard box of 7 blisters. Pack size 70 tablets.
  • PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 9 blisters. Pack size 90 tablets.
  • PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 8 blisters. Pack size 80 tablets.
  • PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 6 blisters. Pack size 60 tablets.
  • PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 50 blisters. Pack size 500 tablets.
  • PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 5 blisters. Pack size 50 tablets.
  • PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 4 blisters. Pack size 40 tablets.
  • PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 3 blisters. Pack size 30 tablets.
  • PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 25 blisters. Pack size 250 tablets.
  • PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 2 blisters. Pack size 20 tablets.
  • PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 10 blisters. Packsize 100 tablets.
  • PVC Aluminium Oriented polyamide Aluminium blister packs. Cardboard box of 1 blister. Pack size 10 tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ecuphar
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lelypharma B.V.
Responsible authority:
  • Swedish Medical Products Agency
Authorisation number:
  • 57536
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0239/001
Concerned member states:
  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Hungary
  • Ireland
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 2/05/2022

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Swedish (PDF)
Published on: 2/05/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."